---
title: "Is Johnson & Johnson Stock Outperforming the S&P 500?"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/267839713.md"
description: "Is Johnson & Johnson Stock Outperforming the S&P 500?"
datetime: "2025-11-28T12:20:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267839713.md)
  - [en](https://longbridge.com/en/news/267839713.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267839713.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/267839713.md) | [繁體中文](https://longbridge.com/zh-HK/news/267839713.md)


# Is Johnson & Johnson Stock Outperforming the S&P 500?


### 相关股票

- [Johnson & Johnson (JNJ.US)](https://longbridge.com/zh-CN/quote/JNJ.US.md)

## 相关资讯与研究

- [Daratumumab becomes first oncology injectable approved for patient administration](https://longbridge.com/zh-CN/news/280990101.md)
- [Orser Capital Management LLC Purchases Shares of 5,217 Johnson & Johnson $JNJ](https://longbridge.com/zh-CN/news/280872064.md)
- [J&J’s Darzalex nets first self-administered cancer injectable approval](https://longbridge.com/zh-CN/news/280822205.md)
- [J&J Says DARZALEX SC Granted EU Approval For First Self-Administered Oncology Treatment](https://longbridge.com/zh-CN/news/280792149.md)
- [Johnson & Johnson Says Icotrokinra Shows Lasting Skin Clearance in Plaque Psoriasis](https://longbridge.com/zh-CN/news/281003119.md)